SCHEMBL14715468

SCHEMBL14715468

Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2nc(N[C@H]3CCCN(C(=O)OC(C)(C)C)C3)ncc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 10/20 0.57
LCK P06239 7/20 0.57
KDR P35968 7/20 0.57
KIT P10721 2/20 0.57
MAPK9 P45984 2/20 0.57
MAPK10 P53779 2/20 0.57
JAK3 P52333 3/20 0.52
USP30 Q70CQ3 1/20 0.52
ABL1 P00519 4/20 0.51
RIPK2 O43353 1/20 0.50
HDAC4 P56524 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
CSF1R P07333 1/20 0.49
CCNK O75909 3/20 0.47
CCNA2 P20248 3/20 0.47
CDK2 P24941 3/20 0.47
CDK7 P50613 3/20 0.47
CCNH P51946 3/20 0.47
MNAT1 P51948 3/20 0.47
CDK12 Q9NYV4 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14568018 1.00 MAPK14 (0.57) MAPK14LCKKDRKITMAPK9
SCHEMBL5496356 0.91 RIPK2 (0.60) MAPK14LCKKDRKITMAPK9
SCHEMBL5496640 0.87 MAPK14 (0.56) MAPK14LCKKDRKITMAPK9
SCHEMBL14724605 0.86 MAPK14 (0.65) MAPK14LCKKDRKITMAPK9
SCHEMBL5488807 0.85 MAPK14 (0.75) MAPK14LCKKDRKITMAPK9
SCHEMBL5491560 0.83 MAPK14 (0.64) MAPK14LCKKDRKITMAPK9
SCHEMBL5498153 0.83 MAPK14 (0.67) MAPK14LCKKDRKITMAPK9
SCHEMBL5497380 0.83 MAPK14 (0.67) MAPK14LCKKDRKITMAPK9
SCHEMBL5501168 0.83 MAPK14 (0.61) MAPK14LCKKDRKITMAPK9
SCHEMBL5500229 0.83 MAPK14 (0.61) MAPK14LCKKDRKITMAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836174-B2 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC (US) 2019-10-02 EP disclosed
EP-1836174-B1 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC (US) 2013-02-27 EP disclosed